In fact, the same PKC isozyme can have opposing roles in cancer, presumably due to complexity of their interactions with numerous substrates and the many secondary messenger systems coupled with their cellular and tissue-specific variability [2, 7]. This evidence concerns the gene PRRT2 and cancer.